Cargando…
Antiarrhythmic Drug Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heritable progressive myocardial disorder that predisposes patients to ventricular arrhythmias and sudden cardiac death. Antiarrhythmic medications have an important role in reducing the frequency of ventricular arrhythmias and the morbidit...
Autores principales: | Gaine, Sean P., Calkins, Hugh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136163/ https://www.ncbi.nlm.nih.gov/pubmed/37189831 http://dx.doi.org/10.3390/biomedicines11041213 |
Ejemplares similares
-
Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Wallace, Ryan, et al.
Publicado: (2021) -
Predicting Heart Failure in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Wang, Weijia, et al.
Publicado: (2022) -
Diagnostic and therapeutic strategies for arrhythmogenic right ventricular dysplasia/cardiomyopathy patient
por: Wang, Weijia, et al.
Publicado: (2019) -
Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy
por: Gasperetti, Alessio, et al.
Publicado: (2023) -
Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
por: Indik, Julia H, et al.
Publicado: (2003)